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041. Introduction
AIDS-Acquired Immunity Deﬁciency Syndrome is the disease
that has affected the whole world in the 20 years since it was
ﬁrst detected. It is caused by Human Immunodeﬁciency Virus
(HIV). 34.3 million People live with HIV infection today that
more than 24 million are in the developing world [1].
There is still much work to be completed in the search for
an anti-HIV vaccine. Set of the chemotherapies are aimed at
killing or halting the pathogen, but treatment which can boost
the immune system can serve to help the body ﬁght infection
on its own [2]. The new treatments are aimed at reducing viral
population and improving the immune response [1,3]. This
brings new hope to the treatment of HIV infection, and wein Shams University.
214 M. Roshanfekr et al.are exploring strategies for such treatments using optimal con-
trol techniques.
There are two kind drugs for treatment of HIV infection
[1,4], the ﬁrst kinds effect on the virus production and reduces
the virus production, the second kinds effect on the CD4+T
cells production and access CD4+T cells production [1,4]. In
this paper, it is presented a control model for medical control
of the chemotherapy treatment that uses the above two con-
trols. Pathologists attempt to obtain drugs that have capability
both works (access CD4+T cells production and reduce virus
production). However some achievements obtained in this
case, but still don’t beget drugs that do this action [5].
Here our purpose was the representation control’s model
that control both cases and minimizing the cost of treatment.
2. The mathematical model
To begin the control procedure, it is necessary to have a model
that describes the infected scenario. In [2] a simple model is gi-
ven which simulates the interaction of immune system with
HIV. This model is used here.
Let T; V represent the concentration of the uninfected
CDþ4 T cells and free infectious virus particles respectively,
and u1, u2 represent two different treatment strategies. As
our control classes we choose measurable functions deﬁned
on a ﬁxed interval (as treatments can’t be continued for inﬁnite
time period due to hazardous side effects) satisfying
0 6 ai 6 ui 6 bi < 1 i= 1,2 For most of HIV chemotherapy
drugs, the length of treatment is less then 500 days [6].
The state system is
dT
dt
¼ s1  s2VðtÞ
B1 þ VðtÞ  lTðtÞ  kVðtÞTðtÞ þ u1ðtÞTðtÞ
dV
dt
¼ gð1 u2ðtÞÞVðtÞ
B2 þ VðtÞ  cVðtÞTðtÞ
ð1Þ
Satisfying V(0) = V0, T(0) = T, where T represents the con-
centration of CDþ4 T cells, V the concentration of HIV parti-
cles. The term s1  s2VðtÞB1þVðtÞ is the source proliferation of
unaffected T cells, lT(t) is the natural loss of uninfected T
cells, kV(t)T(t) is loss by infection, gð1u2ðtÞÞVðtÞ
B2þVðtÞ is viral contribu-
tion to plasma and cV(t)T(t) is the viral loss. Similarly, l is
death rate of T cells, k is infection rate of T cells, g is the input
rate of an external virus source, c is the loss rate of virus and
B1, B2 are half saturation constants. The controls u1 and u2
represent the immune boosting and viral suppressing drugsTable 1 The deﬁnitions and numerical data for the param-
eters [3].
Parameters and constant Values
s1 2 d
1 mm3
s2 1.5 d
1 mm3
l 0.002 d1
k 2.5 · 102 d1 mm3
g 30 d1 mm3
c 0.007 cd1 mm3
b1 14
b2 1respectively. The deﬁnitions and numerical data for the param-
eters can be found in Table 1.
The objective functional to be maximized is
Jðu1; u2Þ ¼
Z tf
0
T A1u21ðtÞ þ A2u22ðtÞ
  
dt ð2Þ
The ﬁrst term represent the beneﬁt of T cells and the other
terms are systemic costs of the drug treatments. The positive
constants A1 and A2 balance the size of the terms, and u
2
1; u
2
2
reﬂect the severity of the side effects of the drugs. When drugs
such as interleukin are administered in high dose, they are
toxic to the human body, which justiﬁes the quadratic terms
in the functional. Our goal is maximizing the number of T cells
and minimizing the systemic cost to the body. We seek an opti-
mal control pair u1; u

2 such that J u

1; u

2
  ¼ maxfJðu1; u2Þj
ðu1; u2Þ 2 Ug where U= {(u1, u2)Œui measurable i= 1, 2
t 2 [0, tf], ai 6 ui 6 bi} is the control set.
Is recommend that the reader see [2–4] for a more complete
background and analysis of the model.
3. Application of measure theory in optimal control problem
3.1. Further analysis of the classical control problem
In the section it is followed from Rubio [7].
Consider:
(i) A real closed interval J= [ta, tb], with ta < tb. the inte-
rior of this interval in the real line will be denoted by
J0 = (ta, tb).
(ii) A bounded, closed, path wise–connected set A in Rn.
(iii) Two elements of A, xa and xb, which are to be the initial
and ﬁnal states of the trajectory of the controlled system.
(iv) A bounded, closed subset U of Rm.
(v) Let X= J · A · U, and f0: Xﬁ R, gi: Xﬁ R; i= 1, 2,
. . ., n. a continuous function.
Consider the differential equation x
 ðtÞ ¼ gðt; xðtÞ;
uðtÞÞ; t 2 J0,
Where the trajectory function x(t) 2 A, t 2 J is a absolutely
continuous and the control function u(t) 2 U, t 2 J is Lebes-
gue-measurable.
Let p= [x(.), u(.)] Be an admissible pair, and B an open
ball in Rn+1 containing J · A; we denote by C0(B) the space
of real-valued continuously differentiable functions on B.
Let / 2 C0(B), and deﬁne
/gðt; x; uÞ ¼ /xðt; xÞtgðt; x; uÞ þ /tðt; xÞ:
/xðt; xÞ ¼
@/
@x1
;
@/
@x2
; . . . ;
@/
@xn
 
; ðt; x; uÞ 2 X ð3Þ
Since p= [x(.), u(.)] is an admissible pair,Z
J
/g½t; xðtÞ; uðtÞdt ¼
Z
J
f/x½t; xðtÞx0ðtÞ þ /t½t; xðtÞgdt
¼
Z
J
_/½t; xðtÞdt
¼ /ðtb; xbÞ  /ðta; xaÞ  D/; ð4Þ
For all / 2 C0(B).
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ued functions with compact support in J0.
Deﬁne
wjðt; x; uÞ ¼ xjw0ðtÞ þ gjðt; x; uÞwðtÞ; j ¼ 1; 2; . . . ; n; w
2 DðJ0Þ: ð5Þ
Then, if p= [x(.), u(.)] is an admissible pair, we have, for
j= 1, 2, . . ., n and w 2 D(J0),
Z
J
wj½t;xðtÞ;uðtÞdt¼
Z
J
xjw
0ðtÞdtþ
Z
J
gj½t;xðtÞ;uðtÞwðtÞdt
¼ xjðtÞwðtÞjJþ
Z
J
x0jðtÞgj½t;xðtÞ;uðtÞ
n o
wðtÞdt¼ 0: ð6Þ
Put /(t, x, u) = h(t). (t, x, u) 2 X, that is a function which de-
pends on the time variable only; then / g(t, x, u) = h0(t), if
p= [x(.), u(.)] is an admissible pair, then the equality (4) for
the function / implies that
Z
J
f½t; xðtÞ; uðtÞdt ¼ af::3.2. Transfer the problem into measure space
Now consider the mapping: Kp: C(X)ﬁ R
KpðfÞ ¼
Z
J
f½t; xðtÞ; uðtÞdt: f 2 CðXÞ ð7Þ
This well deﬁned mapping is linear, positive, continuous, and
injection (see Rubio [6]) therefore, can be identiﬁed pairs
p= [x(.), u(.)] with the linear functional Kp.
Some authors deﬁne such a functional as positive Radon
measure (see Rubio [7]),
Using this approach, the above optimal control now can be
written as follows:
Minimize Kpðf0Þ
Subject to : Kpð/gÞ ¼ D/; / 2 C0ðBÞ:
KpðwjÞ ¼ 0; j ¼ 1; 2; . . . ; n w 2 DðJ0Þ ð8Þ
KpðfÞ ¼ af; f 2 C1ðXÞ
A Radon measure on X can be identiﬁed with a regular Borel
measure on this set (see Rubio [6]), thus KpðfÞ ¼R
X fdl ¼ lðfÞ f 2 CðXÞ.
The space of all positive Radon measures on C(X) will be
denoted by M+(X).
We seek a measure in M+(X), to be normally denoted by
l*, which minimizes
The functional
l 2 MþðXÞ ! lðf0Þ 2 R ð9Þ
Subject to the constraints
lð/gÞ ¼ D/ / 2 C0ðBÞlðwjÞ ¼ 0 j ¼ 1; 2; . . . ; n & w 2 DðJ0Þ
lðfÞ ¼ af f 2 C1ðJ0Þ:
ð10Þ
The existence of the optimal measure for problem (9)
and (10) is based on analysis described in Farahi et al.
[8].3.3. Approximation
We considering the minimization of lﬁ l(f0) over a subset of
M+(X) deﬁned by requiring that only a ﬁnite number of the
constraints in (10) are satisﬁed.
Consider the ﬁrst set of equalities in (10). Let the set
{/iŒi= 1, 2, . . .} be such that the linear combinations of the
function /i 2 C0(B) are uniformly dense in the space
C0(B). For instance, these functions can be taken to bemono-
mials in the components of the n-vector x and the variable t.
Consider the function in D(J0) deﬁned by
wðtÞ ¼ sin½2prðt taÞ=Dt t 2 J
0
0 t R J0
(
;
wðtÞ ¼ 1 cos½2prðt taÞ=Dt t 2 J
0
0 t R J0
( ð11Þ
where Dt= tb  ta and r= 1, 2, 3, . . . . We shall call
{vhŒh= 1, 2, . . .} the sequence of functions of the type wj(t,
x, u) = xjw0(t) + gj(t, x, u)w(t). j= 1, 2, . . ., n, deﬁned in
(10), when the functions w(t) are the sine and cosine functions
(14) deﬁned above and
j ¼ 1; 2; . . . ; n
Theorem 3.1. Consider the linear program consisting in mini-
mizing the function lﬁ l(f0) over the set Q(M1, M2) of
measures in M+(X) satisfying
lð/gi Þ ¼ D/i i ¼ 1; 2; . . . ;M1
lðvhÞ ¼ 0 h ¼ 1; 2; . . . ;M2
ð12Þ
As M1 and M2 tend to inﬁnity, gðM1;M2Þ ¼ inf lðfÞQðM1 ;M2Þ
tends to g= infl(f0)Q.
For proof see Farahi, et al. [8,9].
The number of constraints in the original linear program
was limited; the underling space is not, however, ﬁnite-
dimensional. It is possible, though, to develop a ﬁnite-
dimensional linear program whose solution can be used to
construct one for the problem of minimizing lﬁ l(f0) over
the set (12).
z was written for the triple (t, x, u) 2 X. A unitary atomic
measure with support the singleton set {z}, to be denoted by
dzðAÞ ¼ 1 z 2 A0 z R A

, is characterized by d(z)(F) = F(z),
F 2 C(X), z 2 X.
It is possible to characterize a measure in the set Q(M1, M2)
at which the linear function lﬁ l(f0) attains its minimum.
Theorem 3.2. The measure l* in the set Q(M1, M2) at which
the function lﬁ l(f0) attains its minimum has the form
l ¼PM1þM2i¼1 ai dzi .
With the triples zi 2 X, and the coefﬁcient
ai P 0; i ¼ 1; 2; . . . ;M1 þM2.
For proof see Rubio [7].
The measure–theoretical optimization problem is equivalent
to a nonlinear optimization problem; we shall take a different
216 M. Roshanfekr et al.road this time, and try somehow to preserve the essential
linearity of the problem. The answer lies in approximating this
support, by introducing a set dense in X:
Theorem 3.3. Let x be a countable dense subset of X. Given
e> 0, a measure m 2 MþðXÞ can be found such that
jðm  mÞf0j 6 e
jðm  mÞ/gi j 6 e i ¼ 1; 2; . . . ;M1:
jðm  mÞvhj 6 e h ¼ 1; 2; . . . ;M2:
The measure m has the form m ¼PM1þM2k¼1 ai dðzkÞ. with the triples
zi 2 x, and the coefﬁcient ai P 0; i ¼ 1; 2; . . . ;M1 þM2.
For proof see Rubio [7].
These results suggest that the following linear program
should be considered. Given e> 0 and zk, zk 2 x, k = 1, 2, . . .,
N, where x is a dense subset of X,
Min
XN
j¼1
ajf0ðzjÞ
Subject to :  e 6
XN
j¼1
aj/
g
i ðzjÞ  D/ 6 e i ¼ 1; 2; . . . ;M1
 e 6
XN
j¼1
ajvhðzjÞ 6 e h ¼ 1; 2; . . . ;M2
ð13Þ
Note that the elements zk 2 x, k = 1, 2, . . ., N, are ﬁxed; the
only unknowns are the numbers ai, i = 1, 2, . . ., N. There are
N unknowns and 2(M1 +M2) inequalities in this linear pro-
gramming problem.
We have chosen functions, hs, s= 0, 1, 2, . . ., L as
hsðtÞ ¼ 1 t 2 Js0 t R Js

, with Js = [ta + (s  1)(tb  ta)/L,
ta + s(tb  ta)/L]
Now consider the optimal control problem
min I ¼ R tb
ta
f0½t; xðtÞ; uðtÞdt
s:t x
 ðtÞ ¼ gi½t; xðtÞ; uðtÞ i ¼ 1; 2; . . . ; n
Let X= J · A · U, divide the region X to N grids XK, so we
have: X ¼ [N
K¼1
XK, and choose zK 2 XK, where zk = (tk, xk,
uk), k = 1, 2, . . ., N. To deﬁne /0s, w0s and h0s functions, we
have chosen M1, M2 and L of these functions respectively, thus:
/gi ðt; x; uÞ ¼ @/iðt;xÞ@x  gðt; x; uÞ i ¼ 1; 2; . . . ;M1
We deﬁne vh functions as follows:
wrj ðt; x; uÞ ¼ xjw0rðtÞ þ gjðt; x; uÞwrðtÞ
where (t, x, u) 2 X, j = 1, 2, . . ., n, r = 1, 2, . . ., 2M2, and we
have:
wrðtÞ ¼ sin½2prðt t0Þ=Dt r¼ 1;2; . . .M2
wrðtÞ ¼ 1 cos½2pðrM21Þðt t0Þ=Dt r¼M21þ 1; . . . ;2M2

ð14Þ
Where M2 = 2M21, h = 1,2, . . ., M2, Dt = t1  t0,
Now the optimal control problem (9) and (10) is approxi-
mated by the following ﬁnite-dimensional linear-programming
problem:min
XN
j¼1
ajf0ðzjÞ
s:t :
XN
J¼1
aj/
g
i ðzjÞ ¼ D/i i ¼ 1; 2; . . . ;M1
XN
j¼1
ajvhðzjÞ ¼ 0 h ¼ 1; 2; . . . ;M2
XN
j¼1
ajhsðzjÞ ¼ as s ¼ 1; 2; . . . ;L
ð15Þ
where D/i = /i(tb, xb)  /i(ta, xa)4. Computational method
In the following the problem (1) was replaced by another one
in which the maximum of the functional (2) calculated over a
set of positive Radon-measure to be deﬁned as follows. We fol-
low the analysis of the previous section.
We consider again state system (1) and for simplicity, it was
assumed that:.V= x2, T= x1 Hence (1) change to:
dx1
dt
¼ s1  s2x2
B1 þ x2  lx1  kx2x1 þ u1ðtÞx1
dx2
dt
¼ gð1 u2ðtÞÞx2
B2 þ x2  cx2x1
ð16Þ
Putting parameters from Table 1 we have
dx1
dt
¼ 2 1:5x2
0:007þx2  0:002x1  0:00025x2x1 þ u1ðtÞx1
dx2
dt
¼ 30ð1u2ðtÞÞx2
14þx2  0:007cx2x1
where the objective functional is as follows:
Jðu1; u2Þ ¼
Z tf
0
x1  A1u21ðtÞ þ A2u22ðtÞ
  
dt:
A1 ¼ 250000; or 500000; and A2 ¼ 75
ð17Þ
The initial values of x1, x2 are given, while the ﬁnal values of
these variables are indeﬁnite. Deﬁne _x ¼ gðt; x; uÞ where
x ¼ x1
x2
	 

; g ¼ g1
g2
	 

so we have
g1ðt;x;uÞ¼
dx1
dt
¼2 1:5x2
0:007þx20:002x10:00025x2x1þu1ðtÞx1
g2ðt;x;uÞ¼
dx2
dt
¼30ð1u2ðtÞÞx2
14þx2 0:007x2x1
ð18Þ
Here the optimal control problems (14) and (15) were approx-
imated by a ﬁnite dimensional linear programming problem.
Suppose t 2 J= [t0, t1], xi 2 Ai; i= 1, 2u1 2 U1 and u2 2 U2.
It was assumed that m1 = 10, m2 = 5, m3 = 5, m4 = 6 and
m5 = 6, are the number of partitions respect to J, A1, A2, U1
and U2, respectively. We deﬁne:
N ¼ m1 m2 m3 m4 m5 ¼ 9000
Let X= J · A1 · A2 · U, where U= (U1, U2) is control func-
tion pair and g: Xﬁ R5 is the continuous function. Now
divide the region X to N grids XK, so we have:
X ¼ [N
K¼1
XK, and choose zK 2 XK, where
zk ¼ tk; xk1; xk2; uk1; uk2
 
; k ¼ 1; 2; . . . ; 9000.
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Figure 1 Optimal controls u1, u1 for A1 = 250000.
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Figure 4 Optimal controls u1, u1 for A1 = 500000.
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So, the approximated linear programming problem which
approximates the action of optimal control problem would be:
max
X9000
j¼1
aj
Z tf
0
xj1 A1u21ðtÞþA2u22ðtÞ
  
dt
	 

s:t 
X9000
j¼1
aj 2 1:5x
j
2
0:007þxj2
0:002xj10:00025xj2xj1þuj1ðtÞxj1
 
þbj1 ¼ 400

X9000
j¼1
aj
30 1uj2ðtÞ
 
xj2
14þxj2
0:007xj2xj1
 !
þbj2 ¼ 2:5
X9000
j¼1
aj
2pixj1
5
cosð2pitj=5Þþg1 sinð2pitj=5Þ
 
¼ 0; i¼ 1;2
X9000
j¼1
aj
2pixj1
5
sinð2pitj=5Þþg1ð1 cosð2pitj=5ÞÞ
 
¼ 0; i¼ 1;2
X9000
j¼1
aj
2pixj2
5
cosð2pitj=5Þþg2 sinð2pitj=5Þ
 
¼ 0; i¼ 1;2
X9000
j¼1
aj
2pixj2
5
sinð2pitj=5Þþg2ð1 cosð2pitj=5ÞÞ
 
¼ 0; i¼ 1;2
X900
j¼1
aj ¼ 1
X1800
j¼901
aj ¼ 1
..
.
X9000
j¼8101
aj ¼ 1
ajP 0; j¼ 1;2;3; . . . ;9000
The linear programming problem has 9000 variables and 20
constraints. This problem was solved for initial values,
A1 = 250000 and A2 = 500000, by using MATLAB’s software
for the following deﬁned intervals:
A1 ¼ ½400; 1000; A2 ¼ ½0; 3:5; U1 ¼ ½0; 0:2 U2
¼ ½0; 0:9; J ¼ ½0; 9
The objective function’s value is equal to 6139.69, and the
piecewise constant controls u1 and u2 shown below.
4.1. Conclusion
There are generated several treatment schedules for various
time periods. A case for two different values of A1 for a 5-
month treatment schedule is illustrated. Figs. 1–3 are plotted
using A1 = 250000; A2 = 75; b1 = 0:02; b2 = 0:9,
Fig. 1 represents the controls u1 and u2 for drug administra-
tion schedule for these parameters.
Fig. 2 represents the number of T cells during our treatment
period. The T cell population increases almost linearly up to5
month.
Fig. 3 represents the virus population during treatment per-
iod. In the beginning, a sharp decrease was showed in the virus
population and after few days it started to increase steadily
with some ﬂuctuations.
Fig. 4 represents the optimal controls u1 and u2 for drug
administration schedule for the second set of parameters.
In the compare of Figs. 5 and 6 for T and V with Figs. 2
and 3, it showed that higher A1 values reduced the T cell pop-
ulation and increased the virus population.
Nowadays the dynamic behavior of the immune system in
dealing with different diseases are expressed in equations and
nonequations forms until the best way to control the immunesystem and treatment be resulted by mathematical science
[6,10].
In the treatment of diseases Factors such as duration of
therapy, the amount of prescribed medication, Intervals for
drugs and treatment costs can form parts of the control of sys-
tem [6].
Considering that the optimal control models made in most
cases leads to the complex nonlinear with high Dimension,
solving these models with the help of the classical methods
optimal control or other numerical methods is very difﬁcult.
In addition in these methods restrictions are imposed on the
system such as the derivative of the functions, which may be
caused that the problem is not answer in the space of derivative
functions [7].
Using of measure method for solving optimal control prob-
lems has some beneﬁts such as using of this method for liner
and nonlinear problems. This method can ﬁnd the answer in
the highest space size and then can be return the answer to
the functions space using the approximation method. The
complexity of problem and high dimension in measure space
douse not so long the time of solution of problems. In measure
method global answer can be found while in the most methods
local answer can be found [7]. Therefore using of measure
method in solving of these problems could be recommended.References
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